跳至主要内容
临床试验/CTRI/2025/04/083810
CTRI/2025/04/083810尚未招募2/3 期

A clinical study on the efficacy of Rohitak Abhaya Kwath in the management of Non Alcoholic Fatty Liver Disease

Dr Neelim Shyam Bharali1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年12月4日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
To assess the effectiveness of Rohitak Abhaya Kwath in the management of

研究概览

简要总结

This is a clinical study of Rohtak Abhaya Keats in management of Non Alcoholic Fatty Liver Disease. This study is done as a mandatory Post graduation thesis work. Total number of 60 patients will be studied for 45 days each.

研究设计

研究类型
Interventional
分配方式
Other
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Patients between 18 to 70 years of age irrespective of the sex.
  • Subjects having complaints of indigestion, pain abdomen, anorexia, fatigue, nausea and fulfilling the criteria of diagnosis.
  • Non alcoholic fatty liver- Grade I, Grade II and Grade III.

排除标准

  • Subjects below 18 years more than 70 years.
  • Pregnancy and lactating mother
  • Any cardiac problem
  • Psychiatric disorders.
  • Stomach ulcer
  • Cancer patients
  • Surgical intervention if any.
  • CLD patients with Ascites.

结局指标

主要结局

To assess the effectiveness of Rohitak Abhaya Kwath in the management of

时间窗: 45 Days

symptomatology of NAFLD

时间窗: 45 Days

次要结局

  • To compare the efficacy of Rohitak Abhaya Kwath with Ursodeoxycholic Acid on LFT, USG WA and Lipid Profile(15th, 30th and 45th day)

研究者

发起方
Dr Neelim Shyam Bharali
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验